Inflection Point Acquisition Corp V <IPEX.O>: Benchmark initiates coverage with buy rating; price target $14
IPEX•Related News
Turning Point Brands tops Q2 sales estimates on modern oral product growth
TPB•
ImmunityBio Q2 net product revenue rises 92%
IBRX•
Albany International Q2 Sales USD 329.482 Million
AIN•
Adapti subsidiaries Ballengee Group, Levelution Sports land marketing deals worth over 2 million
ADTI•
Sunoco Q2 FY26 net income more than doubles to $283 million; revenue rises to $14.26 billion
SUN•